Literature DB >> 27499208

Iron depletion-induced downregulation of N-cadherin expression inhibits invasive malignant phenotypes in human esophageal cancer.

Seishi Nishitani1, Kazuhiro Noma1, Toshiaki Ohara1, Yasuko Tomono2, Shinichiro Watanabe1, Hiroshi Tazawa1, Yasuhiro Shirakawa1, Toshiyoshi Fujiwara1.   

Abstract

Esophageal carcinomas often have a poor prognosis due to early lymph node metastasis. Epithelial-mesenchymal transition (EMT) is strongly associated with the acquisition of cancer metastasis and invasion. However, there is no established treatment to eliminate the EMT of cancer cells. Iron is an essential element for both normal and cancer cells in humans. Recently, iron depletion has been discovered to suppress tumor growth. Therefore, we hypothesized that decreased iron conditions would regulate EMT phenotypes, as well as suppressing tumor growth. The human TE esophageal cancer cell lines and OE19 were used in our study. Decreased iron conditions were made using an iron-depletion diet in mice and the iron chelator deferasirox for cell studies. Migration and invasion abilities of cells were measured using migration, invasion, and sphere-formation assays. Esophageal subcutaneous tumor growth was suppressed in decreased iron conditions. In vitro study showed that decreased iron conditions inhibited esophageal cancer cell proliferation as well as migration and invasion abilities, with downregulation of N-cadherin expression. Also, migration and invasion abilities were suppressed by inhibiting expression of N-cadherin. In conclusion, decreased iron conditions revealed a profound anticancer effect by the suppression of tumor growth and the inhibition of migration and invasion abilities via N-cadherin.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27499208     DOI: 10.3892/ijo.2016.3640

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment.

Authors:  Gulimirerouzi Fnu; Georg F Weber
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

2.  Iron depletion is a novel therapeutic strategy to target cancer stem cells.

Authors:  Takayuki Ninomiya; Toshiaki Ohara; Kazuhiro Noma; Yuki Katsura; Ryoichi Katsube; Hajime Kashima; Takuya Kato; Yasuko Tomono; Hiroshi Tazawa; Shunsuke Kagawa; Yasuhiro Shirakawa; Fumiaki Kimura; Ling Chen; Tomonari Kasai; Masaharu Seno; Akihiro Matsukawa; Toshiyoshi Fujiwara
Journal:  Oncotarget       Date:  2017-10-12

3.  Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.

Authors:  Mingzhi Han; Ran Xu; Shuai Wang; Ning Yang; Shilei Ni; Qing Zhang; Yangyang Xu; Xin Zhang; Chao Zhang; Yuzhen Wei; Jianxiong Ji; Bin Huang; Di Zhang; Anjing Chen; Wenjie Li; Rolf Bjerkvig; Xingang Li; Jian Wang
Journal:  Neoplasia       Date:  2018-05-03       Impact factor: 5.715

4.  A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness.

Authors:  Yuki Katsura; Toshiaki Ohara; Kazuhiro Noma; Takayuki Ninomiya; Hajime Kashima; Takuya Kato; Hiroaki Sato; Satoshi Komoto; Toru Narusaka; Yasuko Tomono; Boyi Xing; Yuehua Chen; Hiroshi Tazawa; Shunsuke Kagawa; Yasuhiro Shirakawa; Tomonari Kasai; Masaharu Seno; Akihiro Matsukawa; Toshiyoshi Fujiwara
Journal:  Cancers (Basel)       Date:  2019-02-03       Impact factor: 6.639

Review 5.  Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology.

Authors:  Rikki A M Brown; Kirsty L Richardson; Tasnuva D Kabir; Debbie Trinder; Ruth Ganss; Peter J Leedman
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

6.  Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

Authors:  Shogo Amano; Seiji Kaino; Shuhei Shinoda; Hirofumi Harima; Toshihiko Matsumoto; Koichi Fujisawa; Taro Takami; Naoki Yamamoto; Takahiro Yamasaki; Isao Sakaida
Journal:  BMC Cancer       Date:  2020-07-22       Impact factor: 4.430

7.  miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.

Authors:  Xueping Feng; Wuwu Lv; Shuanglian Wang; Qian He
Journal:  Oncol Rep       Date:  2018-07-02       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.